Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT00496535
Eligibility Criteria:
Inclusion Criteria:
* Head and neck cancer
* Patients must have a locoregional tumor amenable to reirradiation with curative intent.
* disease, or the majority of disease, should be accessible to injection via direct intratumoral injection
* Life expectancy of greater than 12 weeks
* Age \> 18 years
* ECOG performance status 0-1
Exclusion Criteria:
* Metastatic disease
* History of malignancy (other than head and neck cancer) in the last 2 years except carcinoma in situ of the cervix or bladder, non-melanomatous skin cancer, or localized early stage prostate cancer, with patients continually disease free, or cancers that are not felt to influence treatment for head and neck cancer and life expectancy of patient
* Patients may not be receiving any other investigational agents currently or within the 4 weeks prior to study Day 1
* Active infection of any type
* Chronic treatment for greater than 6 months with steroids
* Pregnant or lactating women
* Patients with known history of cerebral vascular disease; stroke or TIA within the last 6 months
* Patients with history of documented thrombosis (PE or DVT), or known coagulopathy or thrombophilia, or evidence of DVT / thromboembolic event upon enrollment
* Patients receiving hormone replacement therapy or hormonal contraceptives within two weeks of day 1
* Patients who have undergone surgery within the last 1 month prior to day 1
* Patients with active carotid artery involvement or status post carotid artery graft / stenting
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00496535
Study Brief:
Protocol Section:
NCT00496535